PREVPAC (COPACKAGED)
LOE ApproachingNDAORALCAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS
Approved
Dec 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PREVPAC is a copackaged oral combination product approved in 1997 for the treatment of Helicobacter pylori infection and related gastrointestinal conditions. The product combines multiple active ingredients in capsule and delayed-release tablet formulations to deliver coordinated therapeutic action. The specific mechanism of action and indication details are not publicly documented in standard references.
LOE Approaching
This product is approaching loss of exclusivity with moderate competitive pressure (30/100), signaling a contracting commercial footprint and likely smaller brand team focused on maximizing remaining patent-protected revenue.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PREVPAC offers limited career growth potential given its LOE-approaching lifecycle stage and minimal linked job openings (0 identified). Career value lies primarily in managing decline, defending market share, and implementing cost-optimization strategies rather than innovation or expansion.
Brand ManagerField Sales Representative
Worked on PREVPAC (COPACKAGED) at Takeda? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.